Author

Ahmed FZ

University of Manchester - Cited by 1,318 - Devices and Heart failure

Biography

Dr. Ahmed FZ is from Department of Cardiology, Manchester Heart Centre, located in United Kingdom. His study is about Extreme Twiddling: Unusual Presentation of an Old Foe. He is also specialized in  ICD, Twiddler’s syndrome, Intracardiac twiddling, Cardiology.  
Title
Cited by
Year
Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
GA Lewis, S Dodd, D Clayton, E Bedson, H Eccleson, EB Schelbert, ...Nature Medicine 27 (8), 1477-1482, 2021202
73
2021
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE …
JGF Cleland, JP Ferreira, B Mariottoni, P Pellicori, J Cuthbert, ...European heart journal 42 (6), 684-696, 2021202
63
2021
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded …
PR Kalra, JGF Cleland, MC Petrie, EA Thomson, PA Kalra, IB Squire, ...The Lancet 400 (10369), 2199-2209, 2022202
55
2022
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic
A Shoaib, HGC Van Spall, J Wu, JGF Cleland, TA McDonagh, M Rashid, ...European Heart Journal-Quality of Care and Clinical Outcomes 7 (4), 378-387, 2021202
50
2021
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept …
P Pellicori, JP Ferreira, B Mariottoni, HP Brunner‐La Rocca, FZ Ahmed, ...European journal of heart failure 22 (9), 1711-1723, 2020202
48
2020
Triage‐HF plus: a novel device‐based remote monitoring pathway to identify worsening heart failure
FZ Ahmed, JK Taylor, C Green, L Moore, A Goode, P Black, L Howard, ...ESC Heart Failure 7 (1), 108-117, 2020202
36
2020
Proteomic and mechanistic analysis of spironolactone in patients at risk for HF
JP Ferreira, J Verdonschot, P Wang, A Pizard, T Collier, FZ Ahmed, ...Heart Failure 9 (4), 268-277, 2021202
34
2021
Cost of inpatient heart failure care and 30-day readmissions in the United States
Cost of inpatient heart failure care and -day readmissions in the United StatesCS Kwok, D Abramov, P Parwani, RK Ghosh, M Kittleson, FZ Ahmad, ...International Journal of Cardiology 329, 115-122, 2021202
30
2021
The impact of COVID‐19 on the management of heart failure: a United Kingdom patient questionnaire study
R Sankaranarayanan, N Hartshorne‐Evans, S Redmond‐Lyon, J Wilson, ...ESC Heart Failure 8 (2), 1324-1332, 2021202
29
2021
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score
FZ Ahmed, C Blomström-Lundqvist, H Bloom, C Cooper, C Ellis, A Goette, ...EP Europace 23 (9), 1446-1455, 2021202
19
2021
HOMAGE Trial Committees and Investigators. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart …
JGF Cleland, JP Ferreira, B Mariottoni, P Pellicori, J Cuthbert, ...Eur Heart J 42 (6), 684-96, 2021202
17
2021
Cost-effectiveness analyses of an absorbable antibacterial envelope for use in patients at increased risk of cardiac implantable electronic device infection in Germany, Italy …
G Boriani, C Kennergren, KG Tarakji, DJ Wright, FZ Ahmed, JM McComb, ...Value in Health 24 (7), 930-938, 2021202
17
2021
Misdiagnosis of heart failure: a systematic review of the literature
CW Wong, J Tafuro, Z Azam, D Satchithananda, S Duckett, D Barker, ...Journal of cardiac failure 27 (9), 925-933, 2021202
14
2021
Lockdown, slow down: impact of the COVID-19 pandemic on physical activity—an observational study
JK Taylor, H Ndiaye, M Daniels, F AhmedOpen heart 8 (1), e001600, 2021202
13
2021
Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality
FZ Ahmed, C Sammut-Powell, CS Kwok, T Tay, M Motwani, GP Martin, ...EP Europace 24 (2), 245-255, 2022202
11
2022
Protecting the most vulnerable during COVID-19 and beyond: a case report on the remote management of heart failure patients with cardiac implantable electronic devices
FZ Ahmed, C Crosbie, M Kahn, M MotwaniEuropean Heart Journal: Case Reports 4 (FI1), 1, 2020202
5
2020
Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
FZ Ahmed, JK Taylor, AV John, MA Khan, AM Zaidi, MA Mamas, ...ESC Heart Failure 8 (5), 3906-3916, 2021202
4
2021
Septal flash as a predictor of cardiac resynchronization therapy response: A systematic review and meta-analysis
S Bennett, J Tafuro, S Duckett, G Heatlie, A Patwala, D Barker, A Cubukcu, ...Journal of Cardiovascular Echography 1 (4), 198, 2021202
3
2021
Expert consensus recommendations for the provision of infective endocarditis services: updated guidance from the Joint British Societies
JAT Sandoe, F Ahmed, P Arumugam, A Guleri, C Horner, P Howard, ...Heart, 20220
3
2023
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
JP Ferreira, T Collier, AL Clark, MA Mamas, HPBL Rocca, S Heymans, ...European Heart Journal-Cardiovascular Pharmacotherapy 8 (2), 149-156, 2022202
3
2022

Referred From: https://scholar.google.com/citations?hl=en&user=Bf3nZ1QAAAAJ

Cited by
Citations 1318
h-index 21
i10-index 31
Recommended Journals
Open Access Journals